- Home
- LTH vs TFX Comparison
LTH vs TFX Comparison
Compare LTH & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTH | TFX |
|---|---|---|
| Founded | 1992 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.3B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LTH | TFX |
|---|---|---|
| Price | $31.72 | $131.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $40.57 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 2.3M | 900.9K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ 124.32 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $2,995,255,000.00 | $1,992,713,000.00 |
| Revenue This Year | $11.98 | $15.97 |
| Revenue Next Year | $11.45 | $5.15 |
| P/E Ratio | $85.74 | ★ N/A |
| Revenue Growth | ★ 14.28 | N/A |
| 52 Week Low | $24.14 | $100.18 |
| 52 Week High | $33.50 | $139.67 |
Technical Indicators
Market Signals| Indicator | LTH | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 66.99 | 58.60 |
| Support Level | $25.20 | $102.20 |
| Resistance Level | N/A | $136.44 |
| Average True Range (ATR) | 1.33 | 4.78 |
| MACD | 0.55 | -1.22 |
| Stochastic Oscillator | 75.68 | 64.68 |
Price Performance
Historical ComparisonAbout LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About TFX Teleflex Incorporated
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.